Search

Your search keyword '"Wulf, Gerald"' showing total 1,006 results
Start Over Author "Wulf, Gerald"
1,006 results on '"Wulf, Gerald"'

53. Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Author

Dreger, Peter, Michallet, Mauricette, Bosman, Paul, Dietrich, Sascha, Sobh, Mohamad, Boumendil, Ariane, Nagler, Arnon, Scheid, Christof, Cornelissen, Jan, Niederwieser, Dietger, Müller, Lutz, Vandenberghe, Elizabeth, Scortechini, Ilaria, Schoemans, Helene, Andersen, Niels S., Finke, Jürgen, Russo, Domenico, Ljungman, Per, Passweg, Jakob, van Gelder, Michel, Durakovic, Nadira, Labussiere-Wallet, Helene, Berg, Tobias, Wulf, Gerald, Bethge, Wolfgang, Bunjes, Donald, Stilgenbauer, Stefan, Canepari, Maria Elisa, Schaap, Michel, Fox, Christopher P., Kröger, Nicolaus, Montoto, Silvia, and Schetelig, Johannes

Published
2019
Full Text
View/download PDF

54. Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

Author

Sellner, Leopold, Schetelig, Johannes, Koster, Linda, Choi, Goda, Blaise, Didier, Beelen, Dietrich, Schianca, Fabrizio Carnevale, Passweg, Jakob, Schanz, Urs, Gyan, Emmanuel, Sora, Federica, Kröger, Nicolaus, Wulf, Gerald. G., Van Gorkom, Gwendolyn, Mayer, Jiri, Orvain, Corentin, Bourhis, Jean Henri, Jindra, Pavel, Potter, Victoria, Zallio, Francesco, Vandenberghe, Elisabeth, Robinson, Stephen, Hayden, Patrick J., Yakoub-Agha, Ibrahim, Montoto, Silvia, and Dreger, Peter

Published
2021
Full Text
View/download PDF

55. Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study

Author

Weller, Jan Frederic, primary, Lengerke, Claudia, additional, Finke, Jürgen, additional, Schetelig, Johannes, additional, Platzbecker, Uwe, additional, Einsele, Hermann, additional, Schroeder, Thomas, additional, Faul, Christoph, additional, Stelljes, Matthias, additional, Dreger, Peter, additional, Blau, Igor W., additional, Wulf, Gerald, additional, Tischer, Johanna, additional, Scheid, Christoph, additional, Elmaagacli, Ahmet, additional, Neidlinger, Helga, additional, Flossdorf, Sarah, additional, Bornhäuser, Martin, additional, Bethge, Wolfgang, additional, Fleischhauer, Katharina, additional, Kröger, Nicolaus, additional, De Wreede, Liesbeth C., additional, and Christopeit, Maximilian, additional

Published
2023
Full Text
View/download PDF

57. P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY

Author

Haupt, Maik, primary, Jäkel, Nadja, additional, Wachsmuth, Maria, additional, Stadler, Michael, additional, Beelen, Dietrich, additional, Finke, Juergen, additional, Alakel, Nael, additional, Hemmati, Philipp, additional, Schönland, Stefan, additional, Bethge, Wolfgang, additional, Wulf, Gerald, additional, Wolff, Daniel, additional, Maria Tischer, Johanna, additional, Wagner-Drouet, Eva, additional, Brandt, Anna, additional, Kröger, Nicolaus, additional, Vucinic, Vladan, additional, Bärmann, Ben-Niklas, additional, Brüggemann, Monika, additional, Gromann, Cora, additional, Müller-Tidow, Carsten, additional, Gökbuget, Nicola, additional, and Mueller, Lutz, additional

Published
2023
Full Text
View/download PDF

58. S225: ALLOGENEIC STEM CELL TRANSPLANTATION FOR NK/T-CELL LYMPHOMA IN THE ERA OF ASPARAGINASE-BASED CHEMOTHERAPY: A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY

Author

Berning, Philipp, primary, Schmitz, Norbert, additional, Ngoya, Maud, additional, Finel, Hevé, additional, Boumendil, Ariane, additional, Wang, Fengrong, additional, Huang, Xiaojun, additional, Hermine, Olivier, additional, Philippe, Laure, additional, Couronné, Lucile, additional, Jaccard, Arnaud, additional, Liu, Dai-Hong, additional, Wu, Depei, additional, Reinhardt, Christian, additional, Chalandon, Yves, additional, Wagner-Drouet, Eva, additional, Kwon, MI, additional, Zhang, XI, additional, Carpenter, Ben, additional, Yakoub-Agha, Ibrahim, additional, Wulf, Gerald, additional, Jimenez, Francisco Lopez, additional, Sanz, Jaime, additional, Wallet, Hélène Labussiere, additional, Shimoni, Avichai, additional, Dreger, Peter, additional, Sureda, Anna, additional, Kim, Won-Seog, additional, and Glass, Bertram, additional

Published
2023
Full Text
View/download PDF

59. S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN

Author

Rücker, Frank G, primary, Bullinger, Lars, additional, Cocciardi, Sibylle, additional, Skambraks, Sabrina, additional, Luck, Tamara J, additional, Weber, Daniela, additional, Schneider, Isabelle, additional, Corbacioglu, Andrea, additional, Gaidzik, Verena I, additional, Jahn, Ekaterina, additional, Jahn, Nikolaus, additional, Kapp-Schwoerer, Silke, additional, Schrade, Anika, additional, Theis, Frauke, additional, Fiedler, Walter, additional, Salih, Helmut R, additional, Wulf, Gerald, additional, Salwender, Hans, additional, Schroeder, Thomas, additional, Götze, Katharina S, additional, Kindler, Thomas, additional, Lübbert, Michael, additional, Schlenk, Richard F, additional, Thol, Felicitas, additional, Heuser, Michael, additional, Ganser, Arnold, additional, Döhner, Hartmut, additional, and Döhner, Konstanze, additional

Published
2023
Full Text
View/download PDF

60. Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients

Author

Treiber, Hannes, primary, Nilius-Eliliwi, Verena, additional, Seifert, Nicole, additional, Vangala, Deepak, additional, Wang, Meng, additional, Seidel, Sabine, additional, Mika, Thomas, additional, Marschner, Dominik, additional, Zeremski, Vanja, additional, Wurm-Kuczera, Rebecca, additional, Caillé, Leandra, additional, Chapuy, Claudia I., additional, Trümper, Lorenz, additional, Fischer, Thomas, additional, Altenbuchinger, Michael, additional, Wulf, Gerald G., additional, Illerhaus, Gerald, additional, Dietrich, Sascha, additional, Schroers, Roland, additional, and Chapuy, Björn, additional

Published
2023
Full Text
View/download PDF

61. Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation

Author

Fuerst, Daniel, Neuchel, Christine, Niederwieser, Dietger, Bunjes, Donald, Gramatzki, Martin, Wagner, Eva, Wulf, Gerald, Glass, Bertram, Pfreundschuh, Michael, Einsele, Hermann, Arnold, Renate, Stuhler, Gernot, Schaefer-Eckart, Kerstin, Freitag, Sebastian, Casper, Jochen, Kaufmann, Martin, Wattad, Mohammed, Hertenstein, Bernd, Klein, Stefan, Ringhoffer, Mark, Mytilineos, Daphne, Tsamadou, Chrysanthi, Mueller, Carlheinz, Schrezenmeier, Hubert, and Mytilineos, Joannis

Published
2016
Full Text
View/download PDF

62. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial

Author

Paschka, Peter, Schlenk, Richard F, Weber, Daniela, Benner, Axel, Bullinger, Lars, Heuser, Michael, Gaidzik, Verena I, Thol, Felicitas, Agrawal, Mridul, Teleanu, Veronica, Lübbert, Michael, Fiedler, Walter, Radsak, Markus, Krauter, Jürgen, Horst, Heinz-A., Greil, Richard, Mayer, Karin, Kündgen, Andrea, Martens, Uwe, Heil, Gerhard, Salih, Helmut R, Hertenstein, Bernd, Schwänen, Carsten, Wulf, Gerald, Lange, Elisabeth, Pfreundschuh, Michael, Ringhoffer, Mark, Girschikofsky, Michael, Heinicke, Thomas, Kraemer, Doris, Göhring, Gudrun, Ganser, Arnold, Döhner, Konstanze, and Döhner, Hartmut

Published
2018
Full Text
View/download PDF

63. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Author

Chapuy, Bjoern, Stewart, Chip, Dunford, Andrew J., Kim, Jaegil, Kamburov, Atanas, Redd, Robert A., Lawrence, Mike S., Roemer, Margaretha G. M., Li, Amy J., Ziepert, Marita, Staiger, Annette M., Wala, Jeremiah A., Ducar, Matthew D., Leshchiner, Ignaty, Rheinbay, Ester, Taylor-Weiner, Amaro, Coughlin, Caroline A., Hess, Julian M., Pedamallu, Chandra S., Livitz, Dimitri, Rosebrock, Daniel, Rosenberg, Mara, Tracy, Adam A., Horn, Heike, van Hummelen, Paul, Feldman, Andrew L., Link, Brian K., Novak, Anne J., Cerhan, James R., Habermann, Thomas M., Siebert, Reiner, Rosenwald, Andreas, Thorner, Aaron R., Meyerson, Matthew L., Golub, Todd R., Beroukhim, Rameen, Wulf, Gerald G., Ott, German, Rodig, Scott J., Monti, Stefano, Neuberg, Donna S., Loeffler, Markus, Pfreundschuh, Michael, Trümper, Lorenz, Getz, Gad, and Shipp, Margaret A.

Published
2018
Full Text
View/download PDF

64. Treosulfan compared with <scp>reduced‐intensity</scp> busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

Author

Beelen, Dietrich, Stelljes, Matthias, Reményi, Péter, Wagner‐Drouet, Eva‐Maria, Dreger, Peter, Bethge, Wolfgang, Ciceri, Fabio, Stölzel, Friedrich, Junghanß, Christian, Labussiere‐Wallet, Hélène, Schaefer‐Eckart, Kerstin, Grigoleit, Goetz U., Scheid, Christof, Patriarca, Francesca, Rambaldi, Alessandro, Niederwieser, Dietger, Hilgendorf, Inken, Russo, Domenico, Socié, Gérard, Holler, Ernst, Glass, Bertram, Casper, Jochen, Wulf, Gerald, Basara, Nadezda, Bieniaszewska, Maria, Stuhler, Gernot, Verbeek, Mareike, La Rocca, Ursula, Finke, Jürgen, Benedetti, Fabio, Pichlmeier, Uwe, Klein, Anja, Baumgart, Joachim, Markiewicz, Miroslaw, and Rocca, Ursula La

Subjects
Leukemia, Myeloid, Acute, Transplantation Conditioning, Myelodysplastic Syndromes, Medizin, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Humans, Prospective Studies, Hematology, Middle Aged, Busulfan, Vidarabine, Aged
Abstract

The phase III study was designed to compare event-free survival (EFS) after treosulfan-based conditioning with a widely applied reduced-intensity conditioning (RIC) busulfan regimen in older or comorbid patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing allogeneic hematopoietic cell transplantation (HCT). A previously reported confirmatory interim analysis of the randomized clinical study including 476 patients demonstrated statistically significant noninferiority for treosulfan with clinically meaningful improvement in EFS. Here, the final study results and pre-specified subgroup analyses of all 570 randomized patients with completed longer-term follow-up are presented. Patients presenting HCT-specific comorbidity index >2 or aged >= 50 years were randomly assigned (1:1) to intravenous (IV) fludarabine with either treosulfan (30 g/m(2) IV) or busulfan (6.4 mg/kg IV) after stratification by disease risk group, donor type, and participating institution. The primary endpoint was EFS with disease recurrence, graft failure, or death from any cause as events. EFS of patients (median age 60 years) was superior after treosulfan compared to RIC busulfan: 36-months-EFS rate 59.5% (95% CI, 52.2-66.1) vs. 49.7% (95% CI, 43.3-55.7) with a hazard ratio (HR) of 0.64 (95% CI, 0.49-0.84), p = 0.0006. Likewise, overall survival (OS) with treosulfan was superior compared to busulfan: 36-month-OS rate 66.8% vs. 56.3%; HR 0.64 (95% CI, 0.48-0.87), p = 0.0037. Post hoc analyses revealed that these differences were consistent with the confirmatory interim analysis, and thereby the treosulfan regimen appears particularly suitable for older AML and MDS patients.

Published
2022
Full Text
View/download PDF

65. Supplementary Figure S4 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

Author

Westin, Jason R., primary, Locke, Frederick L., primary, Dickinson, Michael, primary, Ghobadi, Armin, primary, Elsawy, Mahmoud, primary, van Meerten, Tom, primary, Miklos, David B., primary, Ulrickson, Matthew L., primary, Perales, Miguel-Angel, primary, Farooq, Umar, primary, Wannesson, Luciano, primary, Leslie, Lori, primary, Kersten, Marie José, primary, Jacobson, Caron A., primary, Pagel, John M., primary, Wulf, Gerald, primary, Johnston, Patrick, primary, Rapoport, Aaron P., primary, Du, Linqiu, primary, Vardhanabhuti, Saran, primary, Filosto, Simone, primary, Shah, Jina, primary, Snider, Julia T., primary, Cheng, Paul, primary, To, Christina, primary, Oluwole, Olalekan O., primary, and Sureda, Anna, primary

Published
2023
Full Text
View/download PDF

66. Supplementary Tables S1-S11 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

Author

Westin, Jason R., primary, Locke, Frederick L., primary, Dickinson, Michael, primary, Ghobadi, Armin, primary, Elsawy, Mahmoud, primary, van Meerten, Tom, primary, Miklos, David B., primary, Ulrickson, Matthew L., primary, Perales, Miguel-Angel, primary, Farooq, Umar, primary, Wannesson, Luciano, primary, Leslie, Lori, primary, Kersten, Marie José, primary, Jacobson, Caron A., primary, Pagel, John M., primary, Wulf, Gerald, primary, Johnston, Patrick, primary, Rapoport, Aaron P., primary, Du, Linqiu, primary, Vardhanabhuti, Saran, primary, Filosto, Simone, primary, Shah, Jina, primary, Snider, Julia T., primary, Cheng, Paul, primary, To, Christina, primary, Oluwole, Olalekan O., primary, and Sureda, Anna, primary

Published
2023
Full Text
View/download PDF

67. Data from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

Author

Westin, Jason R., primary, Locke, Frederick L., primary, Dickinson, Michael, primary, Ghobadi, Armin, primary, Elsawy, Mahmoud, primary, van Meerten, Tom, primary, Miklos, David B., primary, Ulrickson, Matthew L., primary, Perales, Miguel-Angel, primary, Farooq, Umar, primary, Wannesson, Luciano, primary, Leslie, Lori, primary, Kersten, Marie José, primary, Jacobson, Caron A., primary, Pagel, John M., primary, Wulf, Gerald, primary, Johnston, Patrick, primary, Rapoport, Aaron P., primary, Du, Linqiu, primary, Vardhanabhuti, Saran, primary, Filosto, Simone, primary, Shah, Jina, primary, Snider, Julia T., primary, Cheng, Paul, primary, To, Christina, primary, Oluwole, Olalekan O., primary, and Sureda, Anna, primary

Published
2023
Full Text
View/download PDF

68. Optimizing the structure of interdisciplinary tumor boards for effective cancer care

Author

Braulke, Friederike, primary, Kober, Kathrin, additional, Arndt, Andreas, additional, Papendick, Maximilian, additional, Strauss, Arne, additional, Kramm, Christof Maria, additional, Thoms, Kai-Martin, additional, König, Alexander, additional, Gaedcke, Jochen, additional, Gallwas, Julia, additional, Wulf, Svenja, additional, Szuszies, Christoph, additional, Wulf, Gerald, additional, Rödel, Ralph, additional, Wolfer, Susanne, additional, Malinova, Vesna, additional, Overbeck, Tobias R., additional, Hinterthaner, Marc, additional, Lotz, Joachim, additional, Nauck, Friedemann, additional, Ernst, Marielle, additional, Stadelmann, Christine, additional, Ströbel, Philipp, additional, Ellenrieder, Volker, additional, Asendorf, Thomas, additional, and Rieken, Stefan, additional

Published
2023
Full Text
View/download PDF

69. Supplementary Figures 1-4 from Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone

Author

Koch, Raphael, primary, Aung, Thiha, primary, Vogel, Daniel, primary, Chapuy, Bjoern, primary, Wenzel, Dirk, primary, Becker, Sabrina, primary, Sinzig, Ursula, primary, Venkataramani, Vivek, primary, von Mach, Tobias, primary, Jacob, Ralf, primary, Truemper, Lorenz, primary, and Wulf, Gerald G., primary

Published
2023
Full Text
View/download PDF

70. Supplementary Figure Legend from Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone

Author

Koch, Raphael, primary, Aung, Thiha, primary, Vogel, Daniel, primary, Chapuy, Bjoern, primary, Wenzel, Dirk, primary, Becker, Sabrina, primary, Sinzig, Ursula, primary, Venkataramani, Vivek, primary, von Mach, Tobias, primary, Jacob, Ralf, primary, Truemper, Lorenz, primary, and Wulf, Gerald G., primary

Published
2023
Full Text
View/download PDF

74. Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

Author

Westin, Jason R., primary, Locke, Frederick L., additional, Dickinson, Michael, additional, Ghobadi, Armin, additional, Elsawy, Mahmoud, additional, van Meerten, Tom, additional, Miklos, David B., additional, Ulrickson, Matthew L., additional, Perales, Miguel-Angel, additional, Farooq, Umar, additional, Wannesson, Luciano, additional, Leslie, Lori, additional, Kersten, Marie José, additional, Jacobson, Caron A., additional, Pagel, John M., additional, Wulf, Gerald, additional, Johnston, Patrick, additional, Rapoport, Aaron P., additional, Du, Linqiu, additional, Vardhanabhuti, Saran, additional, Filosto, Simone, additional, Shah, Jina, additional, Snider, Julia T., additional, Cheng, Paul, additional, To, Christina, additional, Oluwole, Olalekan O., additional, and Sureda, Anna, additional

Published
2023
Full Text
View/download PDF

76. Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients:an EBMT Transplant Complications Working Party study

Author

Ruutu, Tapani, Peczynski, Christophe, Houhou, Mohamed, Polge, Emmanuelle, Mohty, Mohamad, Kröger, Nicolaus, Moiseev, Ivan, Penack, Olaf, Salooja, Nina, Schoemans, Hélène, Duarte, Rafael F., Schroeder, Thomas, Passweg, Jakob, Wulf, Gerald G., Ganser, Arnold, Sica, Simona, Arat, Mutlu, Salmenniemi, Urpu, Broers, Annoek E.C., Bourhis, Jean Henri, Rambaldi, Alessandro, Maertens, Johan, Halaburda, Kazimierz, Zuckerman, Tsila, Labussière-Wallet, Hélène, Basak, Grzegorz, Koenecke, Christian, Perić, Zinaida, Ruutu, Tapani, Peczynski, Christophe, Houhou, Mohamed, Polge, Emmanuelle, Mohty, Mohamad, Kröger, Nicolaus, Moiseev, Ivan, Penack, Olaf, Salooja, Nina, Schoemans, Hélène, Duarte, Rafael F., Schroeder, Thomas, Passweg, Jakob, Wulf, Gerald G., Ganser, Arnold, Sica, Simona, Arat, Mutlu, Salmenniemi, Urpu, Broers, Annoek E.C., Bourhis, Jean Henri, Rambaldi, Alessandro, Maertens, Johan, Halaburda, Kazimierz, Zuckerman, Tsila, Labussière-Wallet, Hélène, Basak, Grzegorz, Koenecke, Christian, and Perić, Zinaida

Abstract

The current incidence, diagnostic policy, management, and outcome of VOD/SOS at EBMT centers were studied. All centers that had performed allogeneic HSCTs in adult patients within one defined year were invited to the study. Seventy-one centers participated with a total of 2886 allogeneic transplantations and 93 cases of VOD/SOS in 2018. The cumulative incidence of VOD/SOS at day 21 was 1.8% and at day 100 2.4%. Of 67 cases with detailed data, 52 were classical and 15 (22%) late onset (>day 21). According to the EBMT criteria, 65/67 patients had at least two VOD/SOS risk factors. The severity grades were: mild 0, moderate 3, severe 29, very severe 35. Fifty-four patients were treated with defibrotide. VOD/SOS resolved in 58% of the patients, 3/3 with moderate, 22/28 with severe, and 12/33 with very severe grade (p < 0.001). By day 100, 57% of the patients were alive; 3/3 with moderate, 22/29 with severe, and 13/35 with very severe VOD/SOS (p = 0.002). In conclusion, the incidence of VOD/SOS was low. Severe and very severe grades dominated. Very severe grade predicted poor outcome compared to severe grade further supporting the concept of early diagnosis and treatment to avoid a dismal outcome. [Figure not available: see fulltext.]

Published
2023

77. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease

Author

Chapuy, Bjoern, Cheng, Hongwei, Watahiki, Akira, Ducar, Matthew D., Tan, Yuxiang, Chen, Linfeng, Roemer, Margaretha G.M., Ouyang, Jing, Christie, Amanda L., Zhang, Liye, Gusenleitner, Daniel, Abo, Ryan P., Farinha, Pedro, von Bonin, Frederike, Thorner, Aaron R., Sun, Heather H., Gascoyne, Randy D., Pinkus, Geraldine S., van Hummelen, Paul, Wulf, Gerald G., Aster, Jon C., Weinstock, David M., Monti, Stefano, Rodig, Scott J., Wang, Yuzhuo, and Shipp, Margaret A.

Published
2016
Full Text
View/download PDF

80. Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT

Author

Spyridonidis, Alexandros, primary, Labopin, Myriam, additional, Savani, Bipin, additional, Giebel, Sebastian, additional, Bug, Gesine, additional, Schönland, Stefan, additional, Kröger, Nicolaus, additional, Stelljes, Matthias, additional, Schroeder, Thomas, additional, McDonald, Andrew, additional, Blau, Igor-Wolfgang, additional, Bornhäuser, Martin, additional, Rovira, Montse, additional, Bethge, Wolfgang, additional, Neubauer, Andreas, additional, Ganser, Arnold, additional, Bourhis, Jean Henri, additional, Edinger, Matthias, additional, Lioure, Bruno, additional, Wulf, Gerald, additional, Schäfer-Eckart, Kerstin, additional, Arat, Mutlu, additional, Peric, Zinaida, additional, Schmid, Christoph, additional, Bazarbachi, Ali, additional, Ciceri, Fabio, additional, Nagler, Arnon, additional, and Mohty, Mohamad, additional

Published
2023
Full Text
View/download PDF

81. First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial

Author

Braulke, Friederike, primary, Zettl, Florian, additional, Ziepert, Marita, additional, Viardot, Andreas, additional, Kahl, Christoph, additional, Prange-Krex, Gabriele, additional, Korfel, Agnieszka, additional, Dreyling, Martin, additional, Bott, Alexander, additional, Wedding, Ulrich, additional, Reichert, Dietmar, additional, de Wit, Maike, additional, Hartmann, Frank, additional, Poeschel, Viola, additional, Schmitz, Norbert, additional, Witzens-Harig, Mathias, additional, Klapper, Wolfram, additional, Rosenwald, Andreas, additional, Wulf, Gerald, additional, Altmann, Bettina, additional, and Trümper, Lorenz, additional

Published
2022
Full Text
View/download PDF

82. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

Author

Ruggeri, Annalisa, de Wreede, Liesbeth C., Müller, Carlheinz R., Crivello, Pietro, Bonneville, Edouard F., Petersdorf, Effie W., Socié, Gerard, Dubois, Valérie, Niittyvuopio, Riitta, Peräsaari, Juha, Yakoub-Agha, Ibrahim, Cornelissen, Jan J., Wieten, Lotte, Gedde-Dahl, Tobias, Forcade, Edouard, Crawley, Charles R., Marsh, Steven G.E., Gandemer, Virginie, Tholouli, Eleni, Bulabois, Claude-Eric, Huynh, Anne, Choi, Goda, Deconinck, Eric, Itäla-Remes, Maija, Lenhoff, Stig, Bengtsson, Mats, Johansson, Jan-Erik, van Gorkom, Gwendolyn, Hoogenboom, Jorinde D., Vago, Luca, Rocha, Vanderson, Bonini, Chiara, Chabannon, Christian, Fleischhauer, Katharina, Clausen, Johannes, Holter, Wolfgang, Kalhs, Peter, Beguin, Yves, Bron, Dominique, Deeren, Dries, Lung, Wu Ka, Kerre, Tessa, Poiré, Xavier, Selleslag, Dominik, Schroyens, Wilfried, Jindra, Pavel, Mayer, Jiri, Vydra, Jan, Zák, Pavel, Nielsen, Bendt, Sengeloev, Henrik, Kaare, Ain, Partanen, Anu, Bay, Jacques-Olivier, Bertrand, Yves, Blaise, Didier, Bourhis, Jean Henri, Chevallier, Patrice, Cluzeau, Thomas, Damaj, Gandhi, Fegueux, Nathalie, Guyotat, Denis, Hunault-Berger, Mathilde, Labussière-Wallet, Hélène, Leleu, Xavier, Lioure, Bruno, Maury, Sebastien, Michel, Gérard, Mohty, Mohamad, Rubio, Marie Thérèse, Tilly, Herve, Turlure, Pascal, Bethge, Wolfgang, Casper, Jochen, Einsele, Hermann, Ganser, Arnold, Kröger, Nicolaus, Martin, Sonja, Platzbecker, Uwe, Reinhardt, Christian, Schäfer-Eckart, Kerstin, Thurner, Lorenz, Valerius, Thomas, Wulf, Gerald G., Karakasis, Dimitrios, Spyridonidis, Alexandros, Hauser, Peter, Reményi, Péter, Reykdal, Sigrun, Mousavi, Ashrafsadat, Angelucci, Emanuele, Arcese, William, Benedetti, Fabio, Bernasconi, Paolo, Biondi, Andrea, Bonifazi, Francesca, Carella, Angelo Michele, Carluccio, Paola, Casini, Marco, Cavanna, Luigi, Ciceri, Fabio, Cimino, Giuseppe, Corradini, Paolo, Fanin, Renato, Galieni, Piero, Grillo, Giovanni, Iori, Anna Paola, La Nasa, Giorgio, Locatelli, Franco, Marotta, Giuseppe, Martino, Massimo, Mazza, Patrizio, Mordini, Nicola, Musso, Maurizio, Olivieri, Attilio, Pavone, Vincenzo, Pane, Fabrizio, Petrini, Mario, Pioltelli, Pietro, Rambaldi, Alessandro, Ruggeri, Marco, Saccardi, Riccardo, Santarone, Stella, Scimè, Rosanna, Sica, Simona, Tarella, Corrado, Velardi, Andrea, Visani, Giuseppe, Zecca, Marco, Tanase, Alina, Kulagin, Aleksandr, Savchenko, Valery, López, Carmen Albo, Amor, Adrián Alegre, López, Jose Luis Bello, Caballero, Dolores, Duarte, Rafael, Cascon, Maria Jesús Pascual, Porras, Rocio Parody, Pérez-Simón, Jose Antonio, Rovira, Montserrat, Sanz, Jaime, Carrete, Juan Pio Torres, Cammenga, Jörg, Isaksson, Cecilia, Mielke, Stephan, Chalandon, Yves, Passweg, Jakob, Schanz, Urs, Meijer, Ellen, Kuball, Jürgen, Veelken, Joan Hendrik, Apperley, Jane, Bloor, Adrian, Byrne, Jenny, Carpenter, Ben, Clark, Andrew, Collin, Matthew, Craddock, Charles, Gibson, Brenda E., Khan, Anjum, Martin, Murray, Medd, Patrick, Nicholson, Emma, Orchard, Kim, Patel, Amit, Peniket, Andy, Potter, Victoria, Snowden, John, Wilson, Keith M.O., RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Transplant. Immunology/Tissue Typing lab, Interne Geneeskunde, MUMC+: MA Hematologie (9), Hematology, IRCCS San Raffaele Scientific Institute [Milan, Italie], EFS, CHU Lille, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Oslo University Hospital [Oslo], CHU Bordeaux [Bordeaux], CHU Pontchaillou [Rennes], Institut de Génétique et Développement de Rennes (IGDR), Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), University of Groningen [Groningen], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), and Essen University Hospital

Subjects
Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, [SDV]Life Sciences [q-bio], HSCT, Medizin, Hematology, Hematologi
Abstract

International audience; Not available.

Published
2023
Full Text
View/download PDF

84. All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study

Author

Schlenk, Richard F., Lübbert, Michael, Benner, Axel, Lamparter, Alexander, Krauter, Jürgen, Herr, Wolfgang, Martin, Hans, Salih, Helmut R., Kündgen, Andrea, Horst, Heinz-A., Brossart, Peter, Götze, Katharina, Nachbaur, David, Wattad, Mohammed, Köhne, Claus-Henning, Fiedler, Walter, Bentz, Martin, Wulf, Gerald, Held, Gerhard, Hertenstein, Bernd, Salwender, Hans, Gaidzik, Verena I, Schlegelberger, Brigitte, Weber, Daniela, Döhner, Konstanze, Ganser, Arnold, Döhner, Hartmut, and for the German-Austrian Acute Myeloid Leukemia Study Group

Published
2016
Full Text
View/download PDF

85. Allogeneic Hematopoietic Stem Cell Transplantation Achieves Long-Term Survival in Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Author

Berning, Philipp, primary, Ngoya, Maud, additional, Schmitz, Norbert, additional, Finel, Hervé, additional, Boumendil, Ariane, additional, Kim, Won-Seog, additional, Wang, Fengrong, additional, Huang, Xiao-jun, additional, Hermine, Olivier, additional, Philippe, Laure, additional, Couronne, Lucile, additional, Jaccard, Arnaud, additional, Liu, Daihong, additional, Wu, Depei, additional, Reinhardt, Hans Christian, additional, Chalandon, Yves, additional, Wagner, Eva Maria, additional, Kwon, Mi, additional, Zhang, Xi, additional, Carpenter, Ben, additional, Yakoub-Agha, Ibrahim, additional, Wulf, Gerald, additional, López Jiménez, Javier, additional, Sanz, Jaime, additional, Labussière-Wallet, Hélène, additional, Shimoni, Avichai, additional, Dreger, Peter, additional, Sureda, Anna, additional, and Glass, Bertram, additional

Published
2022
Full Text
View/download PDF

87. Organ Complications after CD19 CAR T-Cell Therapy for Large B Cell Lymphoma. a Retrospective Study from the EBMT Transplant Complications and Lymphoma Working Partys

Author

Penack, Olaf, primary, Peczynski, Christophe, additional, Koenecke, Christian, additional, Polge, Emmanuelle, additional, Potter, Victoria, additional, Yakoub-Agha, Ibrahim, additional, Fegueux, Nathalie, additional, Daskalakis, Michael, additional, Collin, Matthew P., additional, Dreger, Peter, additional, Kröger, Nicolaus, additional, Schanz, Urs, additional, Bloor, Adrian, additional, Ganser, Arnold, additional, Besley, Caroline, additional, Wulf, Gerald, additional, Novak, Urban, additional, Moiseev, Ivan, additional, Schoemans, Helene, additional, Basak, Grzegorz W, additional, Chabannon, Christian, additional, Sureda, Anna, additional, Glass, Bertram, additional, and Peric, Zinaida, additional

Published
2022
Full Text
View/download PDF

88. Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1-Mutated Acute Myeloid Leukemia

Author

Döhner, Hartmut, primary, Weber, Daniela, additional, Krzykalla, Julia, additional, Fiedler, Walter, additional, Kühn, Michael W.M., additional, Schroeder, Thomas, additional, Mayer, Karin, additional, Lübbert, Michael, additional, Wattad, Mohammad, additional, Götze, Katharina, additional, Fransecky, Lars, additional, Koller, Elisabeth, additional, Wulf, Gerald, additional, Schleicher, Jan, additional, Ringhoffer, Mark, additional, Greil, Richard, additional, Hertenstein, Bernd, additional, Krauter, Jürgen, additional, Martens, Uwe M., additional, Nachbaur, David, additional, Samra, Maisun Abu, additional, Machherndl-Spandl, Sigrid, additional, Basara, Nadezda, additional, Leis, Claudia, additional, Schrade, Anika, additional, Kapp-Schwoerer, Silke, additional, Bullinger, Lars, additional, Thol, Felicitas R., additional, Heuser, Michael, additional, Paschka, Peter, additional, Gaidzik, Verena I., additional, Saadati, Maral, additional, Benner, Axel, additional, Schlenk, Richard F., additional, Döhner, Konstanze, additional, and Ganser, Arnold, additional

Published
2022
Full Text
View/download PDF

89. CART Therapy or Allogeneic Stem Cell Transplantation in ≥ Third Line Treatment of Large B Cell Lymphoma (LBCL)

Author

Glass, Bertram, primary, Sureda, Anna, additional, Boumendil, Ariane, additional, Dreger, Peter, additional, Corradini, Paolo, additional, Ram, Ron, additional, Kroeger, Nicolaus, additional, Castagna, Luca, additional, Pabst, Thomas, additional, Kwon, Mi, additional, Wulf, Gerald, additional, Martín García-Sancho, Alejandro, additional, Solano, Carlos, additional, Stelljes, Matthias, additional, Reinhardt, Hans Christian, additional, Rubio, Marie Thérèse, additional, Malladi, Ram, additional, Blaise, Didier, additional, Besley, Caroline, additional, Forcade, Edouard, additional, von Bonin, Malte, additional, Finke, Jürgen, additional, Hilgendorf, Inken, additional, Martínez-López, Joaquín, additional, Perez-Simon, Jose A., additional, Bethge, Wolfgang, additional, and Schmitz, Norbert, additional

Published
2022
Full Text
View/download PDF

90. Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST)

Author

Sockel, Katja, primary, Frank, Sandra, additional, Neu, Annika, additional, Ditschkowski, Markus, additional, Hilgendorf, Inken, additional, Goeckenjan, Mareen, additional, Stoelzel, Friedrich, additional, Middeke, Jan Moritz, additional, Kröger, Nicolaus, additional, Ayuk, Francis A., additional, Eder, Matthias, additional, Bethge, Wolfgang, additional, Finke, Jürgen, additional, Bertz, Hartmut, additional, Kobbe, Guido, additional, Kaufmann, Martin, additional, Platzbecker, Uwe, additional, Beverungen, David, additional, Schmid, Christoph, additional, von Bonin, Malte, additional, Egger-Heidrich, Katharina, additional, Heberling, Lisa, additional, Trautmann-Grill, Karolin, additional, Teipel, Raphael, additional, Bug, Gesine, additional, Tischer, Johanna, additional, Fraccaroli, Alessia, additional, Holler, Barbara, additional, Wolff, Daniel, additional, Luft, Thomas, additional, Roesler, Wolf, additional, Schäfer-Eckart, Kerstin, additional, Dressler, Sabine, additional, Scheid, Christof, additional, Holtick, Udo, additional, Klein, Stefan, additional, Blau, Igor Wolfgang, additional, Burchert, Andreas, additional, Wulf, Gerald, additional, Hasenkamp, Justin, additional, Schwerdtfeger, Rainer, additional, Kaun, Stephan, additional, Wittke, Christoph, additional, Wortmann, Friederike, additional, Neidlinger, Helga, additional, Bornhaeuser, Martin, additional, Schetelig, Johannes, additional, and of the German Cooperative Transplant Study Group, on Behalf, additional

Published
2022
Full Text
View/download PDF

91. Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation

Author

Spyridonidis, Alexandros, primary, Labopin, Myriam, additional, Gedde-Dahl, Tobias, additional, Ganser, Arnold, additional, Stelljes, Matthias, additional, Craddock, Charles, additional, Wagner, Eva Maria, additional, Versluis, Jurjen, additional, Schroeder, Thomas, additional, Blau, Igor Wolfgang, additional, Wulf, Gerald, additional, Dreger, Peter, additional, Olesen, Gitte, additional, Sengeloev, Henrik, additional, Kröger, Nicolaus, additional, Potter, Victoria, additional, Forcade, Edouard, additional, Passweg, Jakob, additional, Peffault de Latour, Régis, additional, Maertens, Johan, additional, Wilson, Keith, additional, Bourhis, Jean-Henri, additional, Savani, Bipin, additional, Ciceri, Fabio, additional, Nagler, Arnon, additional, and Mohty, Mohamad, additional

Published
2022
Full Text
View/download PDF

92. Cardiovascular and metabolic determinants of quality of life in patients with cancer

Author

Evertz, Ruben, primary, Gödde, Katharina, additional, Diehl, Christine, additional, Valentova, Miroslava, additional, Garfias‐Veitl, Tania, additional, Braulke, Friederike, additional, Wulf, Gerald G., additional, Overbeck, Tobias R., additional, Bleckmann, Annalen, additional, König, Alexander O., additional, Weinländer, Pia, additional, Potthoff, Sophia, additional, Hadzibegovic, Sara, additional, Lena, Alessia, additional, Keller, Ulrich, additional, Landmesser, Ulf, additional, Schuster, Andreas, additional, Anker, Markus S., additional, Hasenfuß, Gerd, additional, and von Haehling, Stephan, additional

Published
2022
Full Text
View/download PDF

94. Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation

Author

Schlenk, Richard F., Kayser, Sabine, Bullinger, Lars, Kobbe, Guido, Casper, Jochen, Ringhoffer, Mark, Held, Gerhard, Brossart, Peter, Lübbert, Michael, Salih, Helmut R., Kindler, Thomas, Horst, Heinz A., Wulf, Gerald, Nachbaur, David, Götze, Katharina, Lamparter, Alexander, Paschka, Peter, Gaidzik, Verena I., Teleanu, Veronica, Späth, Daniela, Benner, Axel, Krauter, Jürgen, Ganser, Arnold, Döhner, Hartmut, and Döhner, Konstanze

Published
2014
Full Text
View/download PDF

95. Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial

Author

Glass, Bertram, Hasenkamp, Justin, Wulf, Gerald, Dreger, Peter, Pfreundschuh, Michael, Gramatzki, Martin, Silling, Gerda, Wilhelm, Christian, Zeis, Matthias, Görlitz, Anke, Pfeiffer, Sebastian, Hilgers, Reinhard, Truemper, Lorenz, and Schmitz, Norbert

Published
2014
Full Text
View/download PDF

100. Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis

Author

Shumilov, Evgenii, primary, Aperdannier, Lena, additional, Schmidt, Nicole, additional, Szuszies, Christoph, additional, Neesse, Albrecht, additional, Hoffknecht, Petra, additional, Khandanpour, Cyrus, additional, Mikesch, Jan-Henrik, additional, Stelljes, Matthias, additional, Boeckel, Göran Ramin, additional, Tepasse, Phil-Robin, additional, Reitnauer, Lea, additional, Koch, Raphael, additional, Hasenkamp, Justin, additional, Bacher, Ulrike, additional, Scheithauer, Simone, additional, Trümper, Lorenz, additional, Schmitz, Norbert, additional, Wulf, Gerald, additional, Kerkhoff, Andrea, additional, Lenz, Georg, additional, Krekeler, Carolin, additional, and Bleckmann, Annalen, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results